Lymphoma
Bladder, Brain, Head & Neck, Hemangiosarcoma, Lymphoma, Mammary, Mast Cell Tumor, Osteosarcoma, Skin, Testicular Cancers
Antiangiogenesis, Chemotherapy, Clinical Trials, Radiation, Surgery, Complementary & Alternative Treatments
Afterlife
Most of the time, lymphoma appears as “swollen glands” (lymph nodes) that can be seen or felt under the neck, in front of the
shoulders, or behind the knee. Occasionally, lymphoma can affect lymph nodes that are not visible or palpable from outside the
body, such as those inside the chest or in the abdomen. Other symptoms include vomiting, diarrhea, loss of appetite, weight loss,
lethargy, difficulty breathing and increased thirst or urinations. Cutaneous lymphosarcoma can cause redness or flakiness of the
skin, ulceration (especially near the lips and on the footpads), itchiness or lumps in the skin.  Clinical signs will vary depending on
the stage of the disease, volume of tumor and anatomic location of the lymphoma.
Definition
Symptoms
Risk Factors
While we understand how lymphomas form, we still do not understand why.  There is speculation that environmental factors such
as exposure to pesticides (especially herbicide 2,3-D) or strong magnetic fields increase the incidence, but there is currently no
strong proof of this. There is also some evidence of a possible genetic correlation, but further studies need to be performed to
determine the exact risk factors involved in canine lymphoma.
Lymphoma is one of the most common cancers seen in dogs.  Although there are breeds that appear to be at
increased risk for this disease, lymphoma can affect any dog of any breed at any age. It accounts for 10-20%
of all cancers in dogs.

Lymphoma (lymphosarcoma or non-Hodgkin's lymphoma) is a malignant cancer that involves the lymphoid
system. In a healthy animal, the lymphoid system is an important part of the body's immune system defense
against infectious agents such as viruses and bacteria. Lymphoid tissue normally is found in many different
parts of the body including lymph nodes, liver, spleen, gastrointestinal tract and skin. Lymphosarcoma is
classified according to the location in the body in which the cancer begins.

These include:
  • Multicentric form occurs in the lymph nodes.
  • Gastrointestinal form occurs in the stomach, intestines, liver and lymph nodes in the abdomen.
  • Mediastinal form occurs in the mediastinum, in front of the heart in an organ called the thymus. Hence
    this form of lymphosarcoma sometimes is called thymic lymphoma.
  • Cutaneous form occurs in the skin.
  • Acute lymphoblastic leukemia occurs when the disease starts in the bone marrow.
  • Miscellaneous forms of lymphosarcoma are less common and include those that begin in the nervous
    system, nasal cavity or kidneys.
Lymphosarcoma occurs in middle-aged to older dogs. In fact, most affected dogs are between 5-9 years of age.  Certain breeds of
dogs have a higher than average risk of developing this disease and include Rottweilers, Scottish terriers, Golden retrievers,
Basset hounds, and German shepherds. Males and females are affected equally. In dogs, there may be a genetic basis for this
disease and, in certain breeds, some families several closely related animals have been affected.
Causes
Diagnosis

The chemotherapy treatment usually consists of a combination of oral and injectable drugs given on a frequent basis. The exact
treatment protocol will vary depending on the veterinarian and financial resources of the dog's family. Below are some common
protocols available for treatment after the initial diagnosis of lymphoma.

Multi-drug protocol : Treatment consists of the use of several chemotherapy drugs (prednisone, L-asparaginase [elspar],
vincristine, cyclophosphamide [cytoxan] and doxorubicin [adriamycin]). Weekly chemotherapy treatments are given for
approximately 8 weeks. The treatments are then spaced to every 2 weeks to complete a total of 6 months of treatment. The
average survival time for patients with stage IIIa or IVa lymphoma treated with this protocol is 1 and 1/2 years.

Doxorubicin alone : The patient is treated with a total of 5 treatments of doxorubicin at 3-week intervals. The average survival time
with this approach is 10-11 months.

COP: This protocol involves a combination of cyclophosphamide in tablet form, vincristine and prednisone. 4 weekly intravenous
injections of vincristine are given, followed by injections at 3-week intervals to complete 6 months of treatment. Cyclophosphamide
is given over 4 days every 3 weeks (4 days on; 17 days off). Prednisone is given daily for 6 months. The average survival time with
this protocol is reported as 8-10 months.

Prednisone alone : This medication is a steroid and can be given in pill form daily at home. The average survival time for patients
with lymphoma treated with prednisone only is 60 days.
Treatment
if the patient is hypercalcemic, assess kidney function, and determine if the dog has normal neutrophil and platelet counts so that  
chemotherapy can safely be administered. Lymphoma can also be diagnosed with x-rays and ultrasound  The exact tests
performed will depend on the location of the tumor.


Once a diagnosis of lymphoma has been established, it is necessary that the cancer be staged. Staging is the process by which
the veterinarian determines to what extent the lymphoma has spread throughout the animal's body. The degree of spread affects
the manner in which a dog is treated.

Stage                                                                 Definition
Stage I       Involvement of a solitary lymph node or lymphoid tissue in a single organ (i.e. nasal cavity)
Stage II      Several lymph nodes in the same general area involved
Stage III     All peripheral lymph nodes involved
Stage IV    Involvement of liver and/or spleen, and/or anterior mediastinum in the chest involved
Stage V     Involvement of bone marrow (some classifications consider cutaneous involvement in this stage)

Substage a        without systemic signs of disease (patient generally has no symptoms)
Substage b        with systemic signs of disease (patient does not feel well)
Prognosis
Some owners choose not to treat dogs that develop lymphoma. The life expectancy of these untreated dogs averages 4 to 6
weeks. Oral prednisone therapy may reduce the swellings and discomfort, but probably will not appreciably extend their life span. It
must also be noted that oral prednisone treatment prior to chemotherapy is not recommended and may actually reduce the
effectiveness of the chemotherapy.

In dogs that do undergo one of the recommended chemotherapy protocols, life expectancy can be extended.  Most dogs with
lymphoma develop medium to high-grade lymphoma that is very responsive to chemotherapy. Greater than 75% of dogs with
lymphoma are expected to achieve a complete remission with chemotherapy. The duration of the first remission is variable,
depending on the chemotherapy protocol used, with median remission times varying from 6 months to 11 months. The second
remission is more difficult to achieve, with approximately 40% of dogs with lymphoma achieving complete remission with a second
course of chemotherapy. Less than 20% of dogs with lymphoma will achieve a third complete remission. Approximately 40-45% of
dogs with lymphoma live one year with treatment. Less than 20% of dogs with lymphoma live 2 years with treatment.  Eventually,
the cancer will infiltrate an organ to such an extent that organ fails (often this is the bone marrow or the liver). The patient loses
his/her appetite, vomits or gets diarrhea, weakens and dies. At some point the tumor becomes resistant to therapy and no further
remissions can be obtained.

However, if  a dog tolerates chemotherapy (fortunately most dogs do) their quality of life can be quite good during the treatment
period. Treatment for lymphoma in the dog is considered one of the more successful cancer treatments and can often be
performed by a local veterinarian without the need to travel long distances to veterinary schools or specialty clinics. It helps to
remember that one year can equate to  almost 10% of a dog's expected life span, therefore, the increased life expectancy with
lymphoma treatment is often well worth it.
Information and
Inspiration when you
need it most
 

Buddy lived longer with lymphoma than
anyone thought possible. Sadly he died
in February 2008.  Read his story of
courage and the protocol he used by  
clicking here.

Read about Hailey's successful battle
with Lymphosarcoma at
http://www.haileybell.homestead.com/Ha
ileysStory.html

Recent research using Artemsinin on
dogs with cancer, specifically lymphoma
and bone cancer has shown promising
preliminary results.

Please see our  
Herbal page for more
information.  Could it be the cure for
some dogs?  We hope so!

Read about Essiac Tea
and why you should
consider using it in your
fight against cancer

New York Times Article:  Lawn Herbicide Called Cancer Risk for Dogs

Dogs whose owners use a herbicide containing 2,4-D are up to twice as likely to develop
lymphatic cancer, a finding that suggests that the plant-killing chemical may be a significant
 health risk.  If your dog has lymphoma, stop treating your lawn immediately.

A diet supplemented with arginine
appears to  increase survival time in
dogs with lymphoma, a cancer that
affects white blood cells. Dogs with this
kind of cancer, similar to non-Hodgkin's
lymphoma in humans, are easily
treated, but as with humans, their cancer
tends to return.

Half of the dogs received a special chow
with the two supplements in it, and the
other half ate chow with soybean oil
added. The two chows were identical in
nutritional value, and formulated to be
equally tasty to the dogs. All the dogs
were being treated with the anti-cancer
drug doxorubicin every three weeks, and
were living at home with their owners.

Previous research has shown that some
polyunsaturated fatty acids, like those
found in fish oil, may help prevent the
growth and spread of cancer tumors,
and may help prevent cachexia -- the
devastating weight loss and muscle
wasting seen in some cancer patients
despite adequate nutrition. Likewise,
arginine supplements have been
reported to improve immune responses,
and might help the body fight cancer.

The dogs were fed one of the chows
twice a day during and after their cancer
treatment. The researchers report that
compared to the control dogs, those
who ate the supplemented chow
showed higher blood levels of two fatty
acids called C20:5 and C22:6 that seem
particularly effective in fighting cancer.
Dogs with more of these fatty acids in
their blood also tended to have more
normal levels of lactic acid, which tends
to accumulate in the blood when
metabolism is disrupted in cancer
patients.

The dogs with higher levels of these two
fatty acids survived longer than those
with lower levels, and had longer
remissions, periods of time before their
disease came back.

Dr. Mercola
http://articles.mercola.com/sites/articles/
archive/2000/04/30/fish-oil-lyphoma.aspx
UPDATE:
Washington State University to offer bone marrow transplants for dogs with cancer
Michael Rollins, Vancouver Sun
Published: Tuesday, May 13, 2008

SEATTLE -- Washington State University plans to start offering bone marrow tranplants for dogs with cancer. They won't be
cheap, with cost at upwards of $20,000.

The bone marrow or stem cell transplant -- a procedure that every year saves tens of thousands of human lives and won for the
Seattle physician who pioneered it the 1990 Nobel Prize in medicine -- appears poised to come full circle and become more widely
available to those who first made it all possible.

"They helped us figure out how to help save ourselves, so this represents a big give-back to the canine species," said Dr. Jeffrey
Bryan, a veterinary oncologist at WSU. Bryan is spearheading a project to soon launch what would be the world's first large-scale
clinical transplant program for dogs. The program is expected to become available to treat dogs with lymphoma this summer.

Bone marrow transplants had been done experimentally in dogs over the decades, Bryan said, and clinically for a few dogs by
some pioneering private-practice veterinarians. However, the procedure has never before been routinely offered as a cancer
therapy for the canine community, he said.
Several studies have linked residential
electromagnetic fields (EMFs) with human
cancers, especially those of the blood. A
new study now suggests that these fields
may pose a similar risk to pets

John S. Reif and his coworkers at
Colorado State University in Ft. Collins
focused their study on 230 dogs
hospitalized with cancer. These included
93 animals with canine lymphoma--a
common blood cancer whose origins
remain unknown.

After characterizing the wiring in each pet's
home, Reif's team measured, whenever
possible, actual magnetic fields where the
dog spent most of its time.

Overhead power lines running along
streets and up to homes constitute the
biggest overall contributor to residential
EMFs (SN: 8/21/93, p.124). And in this
study, factors associated with those lines
also showed the strongest link to
lymphoma. They included high front-yard
fields (more than 2 milligauss) or "open
secondary" wires (that have been
associated with very high fields).
Compared to animals whose homes were
fed by buried power lines, dogs exposed
to these factors faced double the cancer
risk--and it tripled if the animal spent 25
percent or more of its time outside.

But the most powerful statistical
association to the cancer occurred in
those 10 dogs whose homes were
located very near a large, "primary" power
distribution line. After adjusting for
potentially confounding variables,
researchers found that the dogs had 13.4
times the lymphoma risk of animals from
homes with buried power lines.

Snuff out Canine Cancer
Candle

A unique candle blending the
best of holistic healing energy
for dogs with cancer.

Click here for more
information or to purchase